财中社11月11日电医脉通(02192)发布公告称,公司于2024年11月11日与M3签订了2024年续约协议,将原有的精准营销及企业解决方案服务框架协议的有效期延长至2027年12月31日。根据协议,公司将继续向M3及其联络人提供数字市场研究服务及数字内容创建与推送服务。历史交易金额显示,2021年、2022年及2023年的年度服务费用分别为984万元、895万元及897万元,而截至2024年6...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.